FLI1
FLI1 (Friend leukaemia integration 1 transcription factor) is a nuclear, sequence-specific transcriptional activator of the ETS family. It is also known as SIC-1, EWSR2 and FLI-1, and is a recurrent partner in chromosomal translocations linked to cancer. Browse Assay Genie's current range of FLI1 research reagents below, or read on for the biology behind the target.
FLI1 is a sequence-specific transcriptional activator. It recognises the DNA sequence 5'-C[CA]GGAAGT-3' and acts in the nucleus, where it binds target sites through its ETS DNA-binding domain to regulate gene expression. The core GGAA motif in this sequence is characteristic of ETS family binding sites.
The FLI1 gene encodes a transcription factor that belongs to the ETS family, the HGNC gene group to which it is assigned as the Fli-1 proto-oncogene, ETS transcription factor. Alternative splicing of the gene results in multiple transcript variants. The mouse ortholog is Fli1, which allows the protein to be studied in murine models.
The previous HGNC name, Friend leukaemia virus integration 1, reflects the history of the gene, and the symbols SIC-1 and EWSR2 are also used in the literature. FLI1 is best known for its role in disease-associated translocations. A t(11;22)(q24;q12) translocation joins the gene to the Ewing sarcoma gene on chromosome 22. The resulting fusion gene is present in the majority of Ewing sarcoma cases. A separate t(4;11)(q21;q23) translocation involving FLI1 has been identified in acute lymphoblastic leukaemia. These rearrangements make FLI1 a frequent subject in studies of transcriptional control and tumour biology, and researchers working with FLI1 antibody, FLI1 ELISA kit or FLI1 protein reagents will often be investigating these contexts.
A t(11;22) translocation fuses FLI1 to the Ewing sarcoma gene, and the fusion is present in the majority of Ewing sarcoma cases.
FLI1 is involved in a t(4;11)(q21;q23) translocation associated with acute lymphoblastic leukaemia, making it relevant to studies of leukaemic rearrangements.
As a sequence-specific activator recognising 5'-C[CA]GGAAGT-3', FLI1 is used to study ETS-dependent control of gene expression.
FLI1 contains an ETS DNA-binding domain, and it is studied alongside other ETS factors to compare DNA recognition and function.
FLI1 is a sequence-specific transcriptional activator located in the nucleus. It recognises the DNA sequence 5'-C[CA]GGAAGT-3' through its ETS DNA-binding domain and activates gene expression from sites containing this motif.
FLI1 is also called FLI-1, SIC-1 and EWSR2, and its previous HGNC name is Friend leukaemia virus integration 1. UniProt names the protein Friend leukaemia integration 1 transcription factor. Alternative splicing produces multiple transcript variants of the gene.
FLI1 is fused to the Ewing sarcoma gene by a t(11;22) translocation in the majority of Ewing sarcoma cases, and a t(4;11) translocation involving it occurs in acute lymphoblastic leukaemia. The mouse ortholog is Fli1; check the datasheet of any product for its validated reactivity.
Related targets with similar gene symbols, including FLII, which is a distinct gene from FLI1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q01543; product specifications from Assay Genie datasheets.